What pfizer pharma does

Pfizer Pharma GmbH is the German operating subsidiary of Pfizer Inc. (NYSE: PFE), headquartered at Friedrichstraße 110, 10117 Berlin, and led by Managing Director Patrick van der Loo. The legal form is a private limited company (GmbH) registered in the commercial register at Amtsgericht Charlottenburg under HRB 114401 B, supervised by the Landesamt für Gesundheit und Soziales, Berlin. The company is a member of the Verband der forschenden Pharma-Unternehmen (vfa) and the Freiwillige Selbstkontrolle für die Arzneimittelindustrie (FSA).

The company's principal digital touchpoint is the PfizerPro portal (pfizerpro.de), a compliance-gated web platform built for verified healthcare professionals in Germany. Access is restricted via DocCheck identity verification in line with the German Heilmittelwerbegesetz (HWG), which prohibits broad public dissemination of prescription drug information. The portal aggregates prescription product information, CME-certified training modules, scientific news, therapy-area content, congress information, and patient support materials. Integrated offerings include the Pfizer Info-Service email subscription and CME-certified eCME training programs. Commercial engagement with HCPs is conducted through a field sales force (Außendienst) offering video consultations, and a Pfizer Medical Information contact center handling inquiries, adverse event reporting, and medical questions on weekdays.

Pfizer Pharma GmbH generates revenue through the sale of prescription medicines and vaccines in Germany, prescribed by physicians and dispensed through pharmacies and hospital pharmacies. Pricing follows the German statutory framework (GKV-Spitzenverband, AMNOSS). The PfizerPro portal functions as a regulatory-compliant marketing and HCP-engagement channel rather than a transactional platform. The wholly-owned subsidiary Pfizer OFG Germany GmbH operates alongside it within the German corporate structure.

Name

pfizer pharma

Legal name

Pfizer Pharma GmbH

Website

https://pfizerpro.de

Company type

Public

Operating status

Operating

Short description

Pfizer Pharma GmbH is the German operating subsidiary of Pfizer Inc. (NYSE: PFE), selling prescription medicines and vaccines through field sales and operating the compliance-gated PfizerPro HCP portal under German HWG regulations.

Ownership category

akta.pro rank

Product category

Prescription Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• Prescription pharmaceuticals
• Medical information services
• Continuing medical education
• Healthcare professional portal
• Pharmaceutical sales Germany

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Marketing or Sales, Personnel, Operations, Others, Infrastructure, Supply Chain

Revenue model

1. Prescription Pharmaceutical Products: Pfizer Pharma GmbH operates as the German subsidiary of Pfizer Inc., generating revenue through the sale of prescription medicines and vaccines. The PfizerPro portal serves as a compliance-gated information channel for healthcare professionals about prescription products, adverse event reporting, and medical inquiries — serving the commercial pharmaceutical business.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Pfizer Pharma GmbH develops, markets, and distributes prescription pharmaceutical products and vaccines in Germany as the local subsidiary of Pfizer Inc. It operates the PfizerPro portal — a compliance-gated, DocCheck-authenticated service and information platform for healthcare professionals providing prescription product information, CME-certified continuing medical education, scientific news, therapy-area content, and patient support materials under the German Heilmittelwerbegesetz (HWG) regulatory framework.

Product overview

PfizerPro is a unified service and information portal for medical professionals in Germany, consisting of a core web platform (PfizerPro) with integrated email subscription services (Pfizer Info-Service/E-Mail-Service) and CME-certified educational offerings (CME-Fortbildungen). The platform provides comprehensive information about Pfizer's pharmaceutical products and therapy areas, including oncology (CDK4/6 inhibition for breast cancer), hemophilia treatments, and smoking cessation. Medical professionals can access news, educational materials, patient resources, and professional development opportunities through a single authenticated portal.

Differentiator

Problem solved

Functional benefit

Products and services

• PfizerPro Portal A service and information portal exclusively for verified medical professionals (HCPs) in Germany, providing comprehensive information about Pfizer's prescription products, therapy areas, CME-certified training, scientific news, patient materials, and professional services. Access is gated via DocCheck login in compliance with the German Heilmittelwerbegesetz (HWG).
• Pfizer Info-Service (E-Mail-Service) An email subscription service for verified healthcare professionals in Germany delivering personalized information about CME training, current clinical studies, congresses, product updates, and educational/patient materials directly to subscribers' inboxes.
• CME-Fortbildungen (Continuing Medical Education) Certified CME (Continuing Medical Education) training modules and e-learning content designed for medical professionals, covering challenges in clinical practice and hospital settings across therapy areas including oncology, hemophilia, and tobacco cessation.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• DocCheckcoreTechnology or IntegrationDocCheck provides identity verification and access control services for the PfizerPro portal. Medical professionals must log in via DocCheck to verify their credentials as healthcare professionals before accessing prescription product information and CME content on PfizerPro. This compliance-gated access is required under the German Heilmittelwerbegesetz (HWG), which restricts prescription drug information to verified medical professionals only.

Scale indicators2 records

Recent moves1 record

Expansion highlights4 records

Direct peers

• Bayer AG: German-headquartered multinational pharmaceutical and life sciences company with a substantial prescription pharmaceutical portfolio (women's health, cardiology, oncology) sold in Germany. Comparable as a fellow branded pharmaceutical company operating in the same German market with similar HCP engagement, CME, and field sales infrastructure.
• Roche: Swiss-headquartered global pharmaceutical company with significant oncology and specialty pharmaceutical operations in Germany. Comparable as a direct competitor in branded pharmaceuticals (especially oncology) with parallel HCP portals, field sales, and CME-certified medical education offerings to German physicians.
• Novartis: Swiss-headquartered global pharmaceutical company with a strong German commercial footprint across specialty pharmaceuticals (cardiology, oncology, immunology). Comparable as a branded pharma competitor with analogous HCP engagement models, CME portals, and field sales presence in Germany.
• Sanofi: French-headquartered global pharmaceutical company with significant German operations including vaccines and specialty pharmaceuticals. Comparable as a branded pharmaceutical competitor with similar HCP portal, CME, and field sales infrastructure serving the German market.
• Merck KGaA: German-headquartered multinational pharmaceutical and life sciences company with healthcare operations in oncology, neurology, and fertility. Comparable as a domestic German branded pharmaceutical competitor with similar HCP-facing channels, CME offerings, and regulatory positioning under HWG and AMNOG.
• Boehringer Ingelheim: German privately-held multinational pharmaceutical company operating in respiratory, cardiovascular, and specialty therapeutics. Comparable as a branded pharma competitor headquartered in Germany with parallel HCP engagement, medical information, and CME infrastructure serving German physicians.
• AbbVie: US-headquartered global pharmaceutical company with significant German commercial operations across immunology, oncology, neuroscience, and aesthetics. Comparable as a branded pharma competitor with similar specialty pharma portfolio, HCP portal, and field sales structure in Germany.
• Johnson & Johnson Innovative Medicine: US-headquartered pharmaceutical division of J&J with substantial German operations across oncology, immunology, and neuroscience. Comparable as a branded pharma competitor with parallel HCP engagement, CME-certified medical education, and field sales coverage in Germany.
• AstraZeneca: British-Swedish multinational pharmaceutical company with strong German oncology, respiratory, and cardiovascular franchises. Comparable as a branded pharma competitor with parallel HCP portal, CME offerings, and field sales coverage operating under HWG and AMNOG regulations in Germany.
• GSK: British-headquartered global pharmaceutical company with German operations in vaccines, specialty medicines, and HIV. Comparable as a branded pharmaceutical competitor with similar HCP engagement infrastructure, field sales, and CME-certified education channels in Germany.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about pfizer pharma